Certified by Founder
Lodge
OncoPep, Inc.
start up
United States
- Boston, Massachusetts
- 09/12/2021
- Series D
- $11,000,000
Through targeting multiple tumor-associated antigens with an investigational multi-peptide vaccine and a multi-tumor antigen adoptive (MTAA) T cell therapy, OncoPep’s T cell focused technologies are designed to be used on their own or in combination with other immunotherapeutics.
- Industry Biotechnology Research
- Website https://oncopep.com/
- LinkedIn https://www.linkedin.com/company/oncopep-inc./
Zócalo Health | $15,000,000 | (Apr 24, 2026)
Rilian | $17,500,000 | (Apr 24, 2026)
BAND | $17,000,000 | (Apr 24, 2026)
Brev.io | $3,300,000 | (Apr 24, 2026)
Maxed | $850,000 | (Apr 24, 2026)
Omni | $120,000,000 | (Apr 24, 2026)
Astor (YC S25) | $5,000,000 | (Apr 24, 2026)
Almanac Health | $10,000,000 | (Apr 24, 2026)
Petual | $20,000,000 | (Apr 24, 2026)
Mosaic(US) | $18,000,000 | (Apr 23, 2026)
C-Infinity | $16,000,000 | (Apr 23, 2026)
Bubble Robotics | $5,000,000 | (Apr 23, 2026)